Ironshore
Ironshore is now part of Collegium Pharmaceutical, Inc.
Ironshore is now part of Collegium Pharmaceutical, Inc.
Ironshore, a biotechnology, health care, and pharmaceutical startup, was founded in 2008 with a focus on developing and commercializing first-in-class treatment options to enhance the quality of life for patients and caregivers. The company's slogan "Change the Delivery, Change the Day.®" encapsulates its commitment to making a meaningful impact in the healthcare industry. Headquartered in the United States, Ironshore secured a significant milestone in its growth with a $200.00M Private Equity Round investment led by Morgan Stanley on 24th January 2017. This investment not only consolidated Ironshore's position in the market but also provided the necessary resources to further its research and development efforts. With a strong focus on innovation and patient-centric solutions, Ironshore is poised to make significant strides in transforming healthcare delivery.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | $200.00M | 1 | Morgan Stanley | 24 Jan 2017 |
No recent news or press coverage available for Ironshore.
We care about your data, and we'd love to use cookies make your experience better.
